California lawmakers try again to cap insulin costs

As many diabetics across the Golden State struggle with insulin costs, California’s efforts to make the medication more affordable have yet to yield results. This year, lawmakers will revisit legislation that would address at least one piece of the affordability puzzle. 

Senate Bill 90, by Sen. Scott Wiener, a San Francisco Democrat, would limit what diabetics pay out of pocket for their insulin — prohibiting state-regulated health insurance plans from imposing a deductible on those prescriptions and capping the copay at $35 for a 30-day supply. The current copay limit is...